Selected articles
Articles for label Krátký Jaroslav are displayed.. Show all articles
STRN‑ALK fusion, rare variant of ALK gene – case report
05/2021 MUDr. Jaromír Roubec, Ph.D.; MUDr. Jaroslav Krátký
In connection with their own case report, the authors discuss the issue of rare mutations in the gene for anaplastic lymphoma kinase (ALK), known mechanisms of increased tumorigenesis of such mutated non-small cell lung cancer tumors and the possibilities of their therapeutic management using tyrosine kinase inhibitors. Literature sources and documented cases of a rare STRN-ALK fusion mutation are presented.
ENTIRE ARTICLE
In connection with their own case report, the authors discuss the issue of rare mutations in the gene for anaplastic lymphoma kinase (ALK), known mechanisms of increased tumorigenesis of such mutated non-small cell lung cancer tumors and the possibilities of their therapeutic management using tyrosine kinase inhibitors. Literature sources and documented cases of a rare STRN-ALK fusion mutation are presented.